PSPradeep Shrestha

Pradeep Shrestha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pradeep Shrestha has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Fluorogenic Imaging Enables the Identification of Phosphoramidate Antibody–Drug Conjugate Linkers

    by Pradeep Shrestha, Veera. V. Shivaji R. Edupuganti, Connor Wang, Nimit L. Patel, Lai Thang, Simone Difilippantonio, Martin J. Schnermann

    Modular, tunable linker chemistries that are stable in circulation yet selectively cleaved are needed to realize the therapeutic potential of antibody-drug conjugates (ADCs). Near-infrared (NIR) fluorogenic imaging using norcyanine carbamate (CyBam) probes can quantitatively compare ADC linkers across in vitro and in vivo settings. A series of substituted CyBams modified with phosphoramidates, peptides, and control triggers were conjugated to EGFR-targeting monoclonal antibody (mAb) panitumumab. Imaging in cellular and in vivo settings reveals the potential for novel phosphoramidate linkers, showing selective cellular activation, excellent tumor localization, and reduced liver signal compared to conventional proteolytic linkers. Guided by these imaging results, monomethyl auristatin E (MMAE) conjugates bearing the new linkers were prepared and displayed picomolar potency, receptor-dependent activity, and promising in vivo tumor growth inhibition. In total, these studies demonstrate that quantitative fluorogenic imaging can enable the discovery and prioritization of new ADC linkers.

  • Open Access

    Fluorogenic Imaging Enables the Identification of Phosphoramidate Antibody–Drug Conjugate Linkers

    by Pradeep Shrestha, Veera. Shivaji R. Edupuganti, Connor Wang, Nimit Patel, Lai Thang, Simone Difilippantonio, Martin Schnermann

    Modular, tunable linker chemistries that are stable in circulation yet selectively cleaved are needed to realize the therapeutic potential of antibody drug conjugates (ADCs). Near-infrared (NIR) fluorogenic imaging using norcyanine carbamate (CyBam) probes can quantitatively compare ADC linkers across in vitro and in vivo settings. A series of substituted CyBams modified with phosphoramidates, peptide, and control triggers were conjugated to the EGFR-targeting monoclonal antibody (mAb) panitumumab. Imaging in cellular and in vivo settings reveal the potential for novel phosphoramidate linkers, showing selective cellular activation, excellent tumor-localization, and reduced liver signal compared to conventional proteolytic linkers. Guided by these imaging results, monomethyl auristatin E (MMAE) conjugates bearing the new linkers were prepared and display picomolar potency, receptor dependent activity and promising in vivo tumor growth inhibition. In total, these studies demonstrate that quantitative fluorogenic imaging can enable the discovery and prioritization of new ADC linkers.

  • Open Access

    Tracking the Fate of Therapeutic Proteins Using Ratiometric Imaging of Responsive Shortwave Infrared Probes

    by Pradeep Shrestha, Nimit Patel, Joseph Kalen, Syed Usama, Martin Schnermann

    Monoclonal antibodies (mAbs) are essential agents for cancer treatment and diagnosis. Advanced optical imaging strategies have the potential to address specific questions regarding their complex in vivo life cycle. This study presents responsive shortwave infrared (SWIR) probes and an associated imaging scheme to assess mAb biodistribution, cellular uptake, and proteolysis. Specifically, we identify a Pegylated benzo-fused norcyanine derivative (Benz-NorCy7) that is activated in acidic environments and can be appended to mAbs without significant changes in optical properties. As a mAb conjugate, this agent shows high tumor specificity in a longitudinal imaging study in a murine model. To enable independent tracking of mAb uptake and lysosomal uptake and retention, a two-color ratiometric imaging strategy was employed using an "always-ON" heptamethine cyanine dye (ex = 785 nm) and the pH-responsive Benz-NorCy7 (ex = 890 nm). To assess proteolytic catabolism, we append a cleavable carbamate to Benz-NorCy7 to create turn-ON probes. These agents facilitate the compari-son of two common peptide linkers and provide insights into their in vivo properties. Overall, these studies provide a strate-gy to assess the fate of protein-based therapeutics using optical imaging in the SWIR range.

  • Top Cited Papers

    meso-Methyl BODIPY Photocages: Mechanisms, Photochemical Properties, and Applications

    by Pradeep Shrestha, Dnyaneshwar Kand, Roy Weinstain, Arthur H. Winter

    meso-methyl BODIPY photocages have recently emerged as an exciting new class of photoremovable protecting groups (PPGs) that release leaving groups upon absorption of visible to near-infrared light. In this Perspective, we summarize the development of these PPGs and highlight their critical photochemical properties and applications. We discuss the absorption properties of the BODIPY PPGs, structure-photoreactivity studies, insights into the photoreaction mechanism, the scope of functional groups that can be caged, the chemical synthesis of these structures, and how substituents can alter the water solubility of the PPG and direct the PPG into specific subcellular compartments. Applications that exploit the unique optical and photochemical properties of BODIPY PPGs are also discussed, from wavelength-selective photoactivation to biological studies to photoresponsive organic materials and photomedicine.


  • Photocaged DNA-Binding Photosensitizer Enables Photocontrol of Nuclear Entry for Dual-Targeted Photodynamic Therapy

    by Elyse M. Digby, Seylan Ayan, Pradeep Shrestha, Elizabeth J. Gehrmann, Arthur H. Winter, Andrew A. Beharry

    Photodynamic therapy (PDT) is a clinically approved cancer treatment that requires a photosensitizer (PS), light, and molecular oxygen─a combination which produces reactive oxygen species (ROS) that can induce cancer cell death. To enhance the efficacy of PDT, dual-targeted strategies have been explored where two photosensitizers are administered and localize to different subcellular organelles. To date, a single small-molecule conjugate for dual-targeted PDT with light-controlled nuclear localization has not been achieved. We designed a probe composed of a DNA-binding PS (Br-DAPI) and a photosensitizing photocage (WinterGreen). Illumination with 480 nm light removes WinterGreen from the conjugate and produces singlet oxygen mainly in the cytosol, while Br-DAPI localizes to nuclei, binds DNA, and produces ROS using one- or two-photon illumination. We observe synergistic photocytotoxicity in MCF7 breast cancer cells, and a reduction in size of three-dimensional (3D) tumor spheroids, demonstrating that nuclear/cytosolic photosensitization using a single agent can enhance PDT efficacy.


  • Efficiency of Functional Group Caging with Second-Generation Green- and Red-Light-Labile BODIPY Photoremovable Protecting Groups

    by Pradeep Shrestha, Atreyee Mukhopadhyay, Komadhie C. Dissanayake, Arthur H. Winter

    BODIPY-based photocages release substrates by excitation with wavelengths in the visible to near-IR regions. The recent development of more efficient BODIPY photocages spurred us to evaluate the scope and efficiency of these second-generation boron-methylated green-light and red-light-absorbing BODIPY photocages. Here, we show that these more photosensitive photocages release amine, alcohol, phenol, phosphate, halides, and carboxylic acid derivatives with much higher quantum yields than first-generation BODIPY photocages and excellent chemical yields. Chemical yields are near-quantitative for the release of all functional groups except the photorelease of amines, which react with concomitantly photogenerated singlet oxygen. In these cases, high chemical yields for photoreleased amines are restored by irradiation under an inert atmosphere. The photorelease quantum yield has a weak relationship with the leaving group pKa of the green-absorbing BODIPY photocages but little relationship with the red-absorbing derivatives, suggesting that factors other than leaving group quality impact the quantum yield. For the photorelease of alcohols, in all cases a carbonate linker (that loses CO2 upon photorelease) significantly increases both the quantum yield and the chemical yield compared to those for direct photorelease via the ether.